Use of Cannabis Oil in Fibromyalgia
Key facts
- Who runs it
- Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 65 people enrolled
- Started
- 19 Oct 2024
- Ended
- 31 Dec 2025
- Type of study
- Observational
- Treatments tested
- Use of cannabis oil
- Record updated
- 26 September 2025
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- written informed consent
- age ≥ 21 years
- diagnosis of FM according to the 2016 American College of Rheumatology (ACR) diagnostic criteria
- failure of previous therapies
Who cannot take part
- psychiatric disorders,
- history of drug or alcohol addiction,
- fatty liver disease or severe liver disease,
- severe cardiopulmonary disease,
- severe renal failure,
- pregnancy or breastfeeding
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Recently, medical cannabis has been shown to be effective in chronic pain conditions such as osteoarthritis, neuropathic pain, and other chronic non-cancer pain.
Read full original descriptionShow less
A study showed that fibromyalgia patients who use cannabis report significant improvement in pain symptoms and quality of life. Patients reported a 50% reduction in pain, and many also reported improvements in sleep and overall well-being. Further research found that the use of medical cannabis among patients with fibromyalgia led to significant improvements in pain, sleep quality, and overall quality of life. This study emphasized that adverse effects were generally mild and tolerable. Furthermore, the systematic review by Fitz et al. concluded that cannabis may be effective in treating fibromyalgia, with preliminary evidence indicating improvements in pain and sleep disturbances. However, it also highlighted the need for further randomized controlled trials to confirm these findings and determine how the cannabinoid system interacts with the pain pathway.
Considering that medical cannabis is effective in treating a variety of symptoms, including pain, cachexia and wasting, sleep disorders, severe or persistent muscle spasms, reduced fatigue in multiple sclerosis, chemotherapy-induced nausea, convulsive disorders, post-traumatic stress disorder, and other conditions in palliative and end-of-life care; with this study, given the premises of the effects of medical cannabis, the aim is to analyze its use also in chronic pain as the main symptom of fibromyalgia syndrome.
Treatments tested
- Use of cannabis oil
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of the Use of Cannabis Oil in Patients With Fibromyalgia
- Record updated
- 26 September 2025